Methyl mercury influences growth-related signaling in MCF-7 breast cancer cells

被引:18
|
作者
Sukocheva, OA
Yang, Y
Gierthy, JF
Seegal, RF
机构
[1] Inst Med & Vet Sci, Hanson Inst, Div Human Immunol, Signal Transduct Lab, Adelaide, SA 5000, Australia
[2] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA
[3] SUNY Albany, Sch Publ Hlth, Albany, NY 12222 USA
关键词
methyl mercury; estrogen; estrogen receptor; Ca2+; Erk1/2; MCF-7 breast cancer cells;
D O I
10.1002/tox.20075
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Environmental contaminants have been shown to alter growth-regulating signaling pathways through molecular mechanisms that are mainly unclear. Here we report that within a narrow concentration range (0.5-1 muM) methyl mercury (MeHg) significantly stimulated growth of MCF-7 cells, induced Ca2+ mobilization, and activated extracellular signal-regulated kinase (1)/(2) (Erk1/2). MeHg modulated E-2-dependent stimulation of growth in a dose-dependent manner, although MeHg neither suppresses nor increases constitutive E-2 metabolism. MeHg demonstrated weak estrogen receptor (ER)-binding ability. However, long preincubation with antiestrogens LY156,758 and ICI164,384 decreased MeHg-induced foci formation, Ca2+ mobilization, and Erk1/2 activation, confirming involvement of ERs. The MeHg-induced increase in [Ca2+](i) was observed to coincide with enhanced Erk1/2 phosphorylation. These data suggest that MeHg can significantly modulate the intracellular signaling environment in MCF-7 cells, resulting in a dose-dependent alteration of ER-mediated estrogenic capacity and therefore should be considered as a potential estrogen-disrupting compound. (C) 2005 Wiley Periodicals, Inc.
引用
收藏
页码:32 / 44
页数:13
相关论文
共 50 条
  • [1] Signaling pathways activated by PACAP in MCF-7 breast cancer cells
    Zibara, Kazem
    Zeidan, Asad
    Mallah, Khalil
    Kassem, Nouhad
    Awad, Ali
    Mazurier, Frederic
    Badran, Bassam
    El-Zein, Nabil
    CELLULAR SIGNALLING, 2018, 50 : 37 - 47
  • [2] Enhanced growth of MCF-7 breast cancer cells overexpressing parathyroid hormone-related peptide
    Falzon, M
    Du, PF
    ENDOCRINOLOGY, 2000, 141 (05) : 1882 - 1892
  • [3] Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells
    Schmidt, K
    Gust, R
    Jung, M
    ARCHIV DER PHARMAZIE, 1999, 332 (10) : 353 - 357
  • [4] PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?
    Maioli, E
    Fortino, V
    BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1293 - 1294
  • [5] PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?
    E Maioli
    V Fortino
    British Journal of Cancer, 2004, 90 : 1293 - 1294
  • [6] Excess methionine inhibits growth of MCF-7 human breast cancer cells
    Kim, HH
    Park, CS
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 141A - 141A
  • [7] Prolidase in human breast cancer MCF-7 cells
    Palka, JA
    Phang, JM
    CANCER LETTERS, 1998, 127 (1-2) : 63 - 70
  • [8] Comparison of the properties of human breast cancer cells: MCF-7 and MCF-7 cells selected for resistance to etoposide
    Cory, AH
    Cory, JG
    ADVANCES IN ENZYME REGULATION, VOL 41, 2001, 41 : 177 - 188
  • [9] Influences of bisphenol-A and 17β-estradiol on the growth of human breast cancer cell (MCF-7)
    Ma, Chun-Yan
    Guo, Li-Li
    Liang, Qian-Jin
    Li, Yan-Ping
    Li, Su-Wen
    Wang, Zi-Jian
    Zhongguo Huanjing Kexue/China Environmental Science, 2002, 22 (05):
  • [10] RELAXIN INFLUENCES THE GROWTH OF MCF-7 BREAST-CANCER CELLS - MITOGENIC AND ANTIMITOGENIC ACTION DEPENDS ON PEPTIDE CONCENTRATION
    BIGAZZI, M
    BRANDI, ML
    BANI, G
    SACCHI, TB
    CANCER, 1992, 70 (03) : 639 - 643